logo

NAUT

Nautilus·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

NAUT fundamentals

Nautilus (NAUT) released its earnings on Oct 28, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -0.11 (YoY +15.38%), beat estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.11
+15.38%
Report date
Oct 28, 2025
NAUT Earnings Call Summary for Q3,2025
  • Tau Proteoform Assay Launch: Early access begins H1 2026, with broadscale proteomics launching late 2026, supported by $168.5M cash runway.
  • Market Validation: 250+ customer interviews confirm Nautilus' iterative mapping as a disruptive, premium solution over mass spectrometry.
  • Operational Efficiency: Q3 2025 OpEx down 19% YoY to $15.5M, with disciplined spending extending cash runway to 2027.
  • Commercial Momentum: Collaborations with top institutions (Allen, Buck) generate real-world data, positioning Nautilus for biomarker discovery in Alzheimer's.
EPS
Revenue

Revenue & Expenses

Key Indicators

Nautilus (NAUT) key financial stats and ratios, covering profitability, financial health, and leverage.
Nautilus (NAUT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Nautilus (NAUT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Nautilus (NAUT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Nautilus (NAUT) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Nautilus (NAUT) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield